Country
Category
Sub Category
Application
Supplier
Physical Form
sustainable
INTERVET
We have found 5 items.
Requestor's contact details | |
Full name | |
Company | |
Position | |
Telephone number | |
Work email address | |
Shipping address |
Thank you. Your request has been sent.
PORCILIS® BEGONIA
PORCILIS® BEGONIA Per dose: At least 105.5 TCID50 of Aujeszky’s disease virus strain Begonia. This strain neither synthesizes thymidine kinase (tk-) nor the glycoprotein 1 (gE-).
Pharmaceutical Ingredients
PORCILIS® PARVO
PORCILIS® PARVO an inactivated vaccine against parvovirus infection for use in pigs. Porcilis Parvo is an inactivated vaccine containing Porcine parvovirus (PPV) strain 014 ≥ 552 EU per dose (as determined in the final product antigenic mass ELISA) in an aqueous adjuvant. The vaccine contains 0.02% formaldehyde as a preservative and 150 mg dl-α tocopherol per dose.
Pharmaceutical Ingredients
PORCILIS® AR-T-DF
PORCILIS® AR-T-DF is a vaccine for use in pigs to reduce atrophic rhinitis in their piglets. Porcilis AR-T DF is a suspension for injection which contains a non-toxic recombinant derivative of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.
Pharmaceutical Ingredients
NUFLOR®
NUFLOR® Florfenicol is a synthetic broad spectrum antibiotic effective against most Gram-positive and Gram-negative bacteria isolated from domestic animals. Florfenicol acts by inhibiting protein synthesis at the ribosomal level and is bacteriostatic.
Pharmaceutical Ingredients
Added to Your Cart
Product Availability by Store Location
Hours